P Charnay
Overview
Explore the profile of P Charnay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
4330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fort E, Pelissier C, Fanjas A, Charnay P, Charbotel B, Bergeret A, et al.
Work
. 2018 May;
60(1):117-128.
PMID: 29843295
Background: Road accidents may impact victims' physical and/or mental health and socio-occupational life, notably including return to work. Objectives: To assess whether the occupational medical consequences sustained by subjects injured...
2.
Stern S, Santos R, Marchetto M, Mendes A, Rouleau G, Biesmans S, et al.
Mol Psychiatry
. 2017 Mar;
23(6):1453-1465.
PMID: 28242870
Bipolar disorder (BD) is a progressive psychiatric disorder with more than 3% prevalence worldwide. Affected individuals experience recurrent episodes of depression and mania, disrupting normal life and increasing the risk...
3.
Nash S, Luaute J, Bar J, Sancho P, Hours M, Chossegros L, et al.
Ann Phys Rehabil Med
. 2014 Oct;
57(9-10):600-17.
PMID: 25267451
Objective: The variety and extent of impairments occurring after traumatic brain injury vary according to the nature and severity of the lesions. In order to better understand their interactions and...
4.
Coulpier F, Decker L, Funalot B, Vallat J, Garcia-Bragado F, Charnay P, et al.
Rev Neurol (Paris)
. 2011 Jan;
167(1):51-6.
PMID: 21193208
CNS/PNS interfaces constitute cell boundaries, since they delimit territories with different neuronal and glial contents. Despite their potential interest in regenerative medicine, the mechanisms restricting oligodendrocytes and astrocytes to the...
5.
Zujovic V, THIBAUD J, Bachelin C, Vidal M, Coulpier F, Charnay P, et al.
Stem Cells
. 2009 Dec;
28(3):470-9.
PMID: 20039366
During development, boundary cap cells (BC) and neural crest cell (NCC) derivatives generate Schwann cells (SC) of the spinal roots and a subpopulation of neurons and satellite cells in the...
6.
Topilko P, Maro G, Charnay P
Rev Neurol (Paris)
. 2008 Mar;
163(12):1252-5.
PMID: 18355477
No abstract available.
7.
Chiron M, Charnay P, Martin J, Vergnes I
Sante Publique
. 2006 May;
18(1):23-39.
PMID: 16676711
Children aged 6 to 11 who have been injured in a traffic accident were observed over a one year period, in parallel with a control group of children. More than...
8.
Voiculescu O, Taillebourg E, Pujades C, Kress C, Buart S, Charnay P, et al.
Development
. 2001 Dec;
128(24):4967-78.
PMID: 11748134
We have previously demonstrated that inactivation of the Krox20 gene led to the disappearance of its segmental expression territories in the hindbrain, the rhombomeres (r) 3 and 5. We now...
9.
Tzavara E, Monory K, GAREL S, Topilko P, Charnay P, Hanoune J
Neuroreport
. 2001 Jun;
12(7):1367-70.
PMID: 11388413
Krox-24 is an immediate early gene encoding a zinc-finger transcription factor implicated in several adaptive responses, and its induction by cannabinoids has been reported. We used mice targeted in the...
10.
Zhu Y, Romero M, Ghosh P, Ye Z, Charnay P, Rushing E, et al.
Genes Dev
. 2001 Apr;
15(7):859-76.
PMID: 11297510
Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder that affects growth properties of neural-crest-derived cell populations. In addition, approximately one-half of NF1 patients exhibit learning disabilities. To characterize NF1...